Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sale of skincare related medical devices and electronic beauty instruments comprising hyaluronic acid repair bio membranes and hyaluronic acid repair dressings used for the protection and care of skin barrier damage after minimally invasive surgery; provision of provision of supply chain management, warehouse services, capital market, and consulting services. In addition, the company offers home-use electronic radiofrequency beauty devices. Further, it offers Qiumei App, an AI system for common skin problems; and medical cosmetic centers that provide vocational training, organization operation, member management, activity planning, and advertising support under the Vvym brand name. The company sells its products under Winona, Winona Baby, AOXMED, Beforteen, Za, and PURE&MILD brand names through offline and online channels, such as e-commerce platforms, retail, large key account (KA) clients, OTC chain clients, commercial companies, and regional distributors. Yunnan Botanee Bio-Technology Group Co.LTD was incorporated in 2010 and is headquartered in Kunming, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 300957-SZ would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2021) — listing | $4,036 0.5× | $5,986 0.5× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 300957
For illustration only — not investment advice. Past performance is not indicative of future results.